VISCOWIN-LD RESPULES
MRP: 360
Packaging: 4X5X2.5ML
Pack Type: respules
Composition:
Ipratropium 500 mg + Levosalbutamol 0.63 mg
Indication:
ASTHMA and COPD - For Paediatric Use
Description:
This inhalation solution combines two effective bronchodilators:
Ipratropium Bromide (500 mcg): An anticholinergic agent that blocks acetylcholine-mediated bronchoconstriction.
Levosalbutamol (0.63 mg): A selective β2-adrenergic agonist that relaxes airway smooth muscle, relieving bronchospasm.
This low-dose formulation is designed for patients who need milder bronchodilation or those sensitive to higher β2-agonist doses. It is suitable for pediatric, geriatric, and sensitive individuals with asthma, COPD, and other obstructive airway diseases.
Tags:
- Dual-action bronchodilation with a mild β2-agonist dose
- Suitable for children and elderly patients
- Effective for acute and maintenance therapy
- Reduces airway resistance and improves oxygenation
- Isotonic formulation for reduced irritation
Usage Information
Dosage
Adults & Children: Use as prescribed; typically 1 respule via nebulizer 2–4 times a day Administer with a jet nebulizer under professional guidance Use immediately after opening unit dose Do not mix with other medications unless instructed
Side Effects
Dry mouth Headache Dizziness Tremor Nervousness Rare: Increased heart rate or paradoxical bronchospasm
Contraindications
Hypersensitivity to ipratropium, levosalbutamol, atropine derivatives Use with caution in cardiovascular diseases, hyperthyroidism, and glaucoma Avoid in patients prone to urinary retention